These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12538912)

  • 1. N-terminal domain of eotaxin-3 is important for activation of CC chemokine receptor 3.
    Shinkai A; Komuta-Kunitomo M; Sato-Nakamura N; Anazawa H
    Protein Eng; 2002 Nov; 15(11):923-9. PubMed ID: 12538912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
    J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.
    Kitaura M; Suzuki N; Imai T; Takagi S; Suzuki R; Nakajima T; Hirai K; Nomiyama H; Yoshie O
    J Biol Chem; 1999 Sep; 274(39):27975-80. PubMed ID: 10488147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2.
    Mayer KL; Stone MJ
    Biochemistry; 2000 Jul; 39(29):8382-95. PubMed ID: 10913244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3.
    Ye J; Mayer KL; Mayer MR; Stone MJ
    Biochemistry; 2001 Jul; 40(26):7820-31. PubMed ID: 11425309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
    Duchesnes CE; Murphy PM; Williams TJ; Pease JE
    Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
    J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eotaxin and monocyte chemotactic protein-3 use different modes of action.
    Chung IY; Kim YH; Choi MK; Noh YJ; Park CS; Kwon DY; Lee DY; Lee YS; Chang HS; Kim KS
    Biochem Biophys Res Commun; 2004 Feb; 314(2):646-53. PubMed ID: 14733956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
    Forssmann U; Uguccioni M; Loetscher P; Dahinden CA; Langen H; Thelen M; Baggiolini M
    J Exp Med; 1997 Jun; 185(12):2171-6. PubMed ID: 9182688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.
    Nibbs RJ; Salcedo TW; Campbell JD; Yao XT; Li Y; Nardelli B; Olsen HS; Morris TS; Proudfoot AE; Patel VP; Graham GJ
    J Immunol; 2000 Feb; 164(3):1488-97. PubMed ID: 10640766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
    Forssmann U; Hartung I; Bälder R; Fuchs B; Escher SE; Spodsberg N; Dulkys Y; Walden M; Heitland A; Braun A; Forssmann WG; Elsner J
    J Immunol; 2004 Sep; 173(5):3456-66. PubMed ID: 15322211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
    Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
    J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding.
    Wan Y; Jakway JP; Qiu H; Shah H; Garlisi CG; Tian F; Ting P; Hesk D; Egan RW; Billah MM; Umland SP
    Eur J Pharmacol; 2002 Dec; 456(1-3):1-10. PubMed ID: 12450563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
    Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
    J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Biol Chem; 2004 May; 279(22):23357-63. PubMed ID: 15039444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines.
    Mayer KL; Stone MJ
    Proteins; 2003 Feb; 50(2):184-91. PubMed ID: 12486712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.